β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate

CARBOHYDRATES

Product Details

CAT No.# CS-CA-00190
Category Carbohydrates
CAS 370100-64-4
Molecular Weight 462.61
Molecular Formula C14H14BrClNNaO8
Synonyms: sodium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate hydrate
Shipping: Free Shipping for worldwide on order above 2000 USD
β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate Worldwide Suppliers of β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate Carbohydrates Clearsynth CS-CA-00190

Product rating: 9 β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate based on 20 ratings

  1. Carbohydrates
  2. β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)




This page contains information about β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate Cas 370100-64-4 and its Carbohydrates.

β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate Worldwide Suppliers of β-D-Glucopyranosiduronic acid 5-bromo-4-chloro-1H-indol-3-yl sodium salt hydrate Carbohydrates Clearsynth 370100-64-4

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."